Sun, 5 May 2024

HEADLINES :


ADVERTISEMENT

Taiwan woman receives US$12,767 compensation after Covid-19 shot
Published on: Saturday, July 29, 2023
By: Bernama
Text Size:

Taiwan woman receives US$12,767 compensation after Covid-19 shot
TAIPEI: A woman has received a compensation of NT$400,000 (US$12,767) after she developed peripheral nerve disorders following a Covid-19 vaccine shot, according to the latest information released by the Vaccine Injury Compensation Programme (VICP).

Central News Agency reported that the VICP held a meeting on June 29 to discuss cases involving reported health problems from taking vaccines and whether these should be compensated.

The meeting saw 170 cases discussed, with 13 cases eligible for compensation ranging from NT$5,000 to NT$400,000.

Of those, five cases involved the AstraZeneca vaccine, three the Moderna vaccine, four the Pfizer-BioNTech vaccine, and one the Medigen vaccine.

CDC Deputy Director General Tseng Shu-huai told reporters on Friday the highest compensation of NT$400,000 was given to a Kaohsiung woman in her 40s.

The woman, surnamed Su felt weakness in the limbs after receiving an AstraZeneca shot and was later diagnosed with polyneuropathy, Tseng said.

Meanwhile, a 17-year-old boy from New Taipei, surnamed Chen, received compensation of NT$10,000, according to the VICP meeting minutes.

The boy felt a tight chest and palpitation two days after his Pfizer-BioNTech shot, and after he went to a hospital, an examination showed he had a rising level of creatine phosphokinasehe.

* Follow us on Instagram and join our Telegram and/or WhatsApp channel(s) for the latest news you don't want to miss.

* Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available.





ADVERTISEMENT






Top Stories Today

World Top Stories


Follow Us  



Follow us on             

Daily Express TV  







close
Try 1 month for RM 18.00
Already a subscriber? Login here
open

Try 1 month for RM 18.00

Already a subscriber? Login here